Literature DB >> 9500228

Presacral carcinoid tumors: report of three cases and review of the literature.

M G Horenstein1, R A Erlandson, D M Gonzalez-Cueto, J Rosai.   

Abstract

The clinical, microscopic, immunohistochemical, and ultrastructural features of three carcinoid tumors of the presacral region are reviewed. All tumors occurred in young women and did not involve the rectum. The predominant microscopic pattern was trabecular. The differential diagnosis included paraganglioma and myxopapillary ependymoma. Immunohistochemically, neuroendocrine markers and low molecular weight cytokeratins were expressed in all cases. Neurosecretory granules were identified in the single case studied by electron microscopy. One case was associated with a tailgut cyst (retrorectal cystic hamartoma). Two patients were treated with complete local excision and are free of disease 3 and 4 years after surgery. One case metastasized to both breasts and recurred locally after an incomplete excision. This report expands the already long list of sites where carcinoid tumors can arise. The frequent association of these tumors with tailgut cysts and their histologic similarities to rectal carcinoid tumors suggest that the most likely derivation of presacral carcinoid tumors is from hindgut rests.

Entities:  

Mesh:

Year:  1998        PMID: 9500228     DOI: 10.1097/00000478-199802000-00015

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

Review 1.  Ghrelin-producing well-differentiated neuroendocrine tumor (carcinoid) of tailgut cyst. Morphological, immunohistochemical, ultrastructural, and RT-PCR study of a case and review of the literature.

Authors:  Stefano La Rosa; Luigi Boni; Giovanna Finzi; Davide Vigetti; Nikolaos Papanikolaou; Silvia Maria Tenconi; Gianlorenzo Dionigi; Moira Clerici; Silvana Garancini; Carlo Capella
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

2.  [Retrorectal space-occupying lesion: a rare differential diagnosis].

Authors:  M Sohn; I Iesalnieks; H Rohrbach; M Fuchs; C H Pfob; K Scheidhauer; A Agha
Journal:  Chirurg       Date:  2016-09       Impact factor: 0.955

Review 3.  Neuroendocrine tumour developing within a long-standing tailgut cyst: case report and review of the literature.

Authors:  Alice Lee; Thomas Surya Suhardja; Thang Chien Nguyen; William Meng-Keat Teoh
Journal:  Clin J Gastroenterol       Date:  2019-05-30

4.  Adenocarcinoma arising in a tailgut cyst with prominent meningothelial proliferation and thyroid tissue: case report and review of the literature.

Authors:  Aleodor A Andea; David S Klimstra
Journal:  Virchows Arch       Date:  2005-02-25       Impact factor: 4.064

5.  [PSAP expression in a primary presacral neuroendocrine tumor. Potential for confusion with prostate cancer].

Authors:  T Menter; A Fischmann; K Glatz
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

6.  Retrorectal tumors.

Authors:  Sean C Glasgow; David W Dietz
Journal:  Clin Colon Rectal Surg       Date:  2006-05

7.  Carcinoid tumors arising in tailgut cysts may be associated with estrogen receptor status: case report and review of the literature.

Authors:  John J Liang; Sadir Alrawi; Gregory N Fuller; Dongfeng Tan
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  Primary neuroendocrine carcinoma of the mediastinum.

Authors:  Füruzan Kacar; Ibrahim Meteoglu; Serdar Sen; Edi Levi
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

Review 9.  Primary neuroendocrine tumor of the sacrum: case report and review of the literature.

Authors:  Fanny Dujardin; Pauline Beaussart; Anne de Muret; Philippe Rosset; Eric Waynberger; Denis Mulleman; Gonzague de Pinieux
Journal:  Skeletal Radiol       Date:  2009-04-10       Impact factor: 2.199

Review 10.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.